Clinical Trials on Colorectal Neoplasms, Hereditary Nonpolyposis in Spain

Total 503 results

Hospital Clinic of Barcelona
Fundacion Clinic per a la Recerca Biomédica

Completed

High Definition White-Light Colonoscopy vs. Chromoendoscopy for Surveillance of Lynch Syndrome. (EndoLynch)

Lynch Syndrome

Spain
Hospital Clinic of Barcelona
European Society of Gastrointestinal Endoscopy

Recruiting

Evaluation of ArTificial Intelligence System (Gi-Genius) for adenoMa dEtection in Lynch Syndrome. (Timely)

Lynch Syndrome

Spain
Fundació Institut de Recerca de l'Hospital de la...

Recruiting

Long-term Results in Intracorporeal Versus Extracorporeal Anastomosis in Laparoscopic Right Colectomy

Colon Cancer | Malignant Neoplasm | Colon Neoplasm, Malignant | Colon Neoplasm | Colon Neoplasia

Spain
MiWEndo Solutions S.L.

Recruiting

Performance and Safety of MiWEndo-assisted Colonoscopy (MiWEndo II)

Colorectal Neoplasms | Colorectal Cancer | Colorectal Adenoma | Colorectal Adenocarcinoma | Colorectal Polyp | Colorectal Adenomatous Polyp

Spain
MiWEndo Solutions S.L.
Hospital Clinic of Barcelona

Completed

Feasibility and Safety of MiWEndo-assisted Colonoscopy (MiWEndo1)

Colorectal Neoplasms | Colorectal Cancer | Colorectal Adenoma | Colorectal Adenocarcinoma | Colorectal Polyp | Colorectal Adenomatous Polyp

Spain
Hospital Clinic of Barcelona
Instituto de Salud Carlos III; Grupo Cooperativo para el Cribado del Cancer... and other collaborators

Completed

Colorectal Cancer Screening in Average-risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy

Colorectal Cancer | Colorectal Neoplasm

Spain
Spanish Cooperative Group for the Treatment of...
Sanofi

Completed

Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based Regimen (AFEMA)

Metastatic Colorectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...
Hoffmann-La Roche

Completed

Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients (AVAXIRI)

Metastatic Colorectal Cancer

Spain
Unidad Integral de Investigación en Oncología S.L.
Hoffmann-La Roche

Completed

1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR.

Metastatic Colorectal Cancer

Spain
Sofia Perea, Director Clinical Trials Unit.

Unknown

RAS Switch in Patients With Metastatic RAS Native Colorectal Tumors Treated With 1st Line FOLFIRI-Cetuximab (BEAMING)

Colorectal Cancer Metastatic

Spain
Spanish Cooperative Group for the Treatment of...
Amgen

Completed

Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC

Metastatic Colorectal Cancer

Spain
Transgene

Terminated

Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors.

Colorectal Neoplasm | Digestive System Neoplasm

France, Spain, Belgium
Spanish Cooperative Group for the Treatment of...
Bayer

Completed

Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC (RE-ARRANGE)

Metastatic Colorectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...
Sanofi

Completed

Phase II Trial to Assess FOLFIRI+Aflibercept Efficacy in Patients With Oxaliplatin-pretreated Metastatic Colorectal Cancer With or Without ACE Polymorphisms (POLAF)

Metastatic Colorectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...

Completed

Safety and Efficacy Study of mFOLFOX-6 Plus Cetuximab for 8 Cycles Followed by mFOLFOX-6 Plus Cetuximab or Single Agent Cetuximab as Maintenance Therapy in Patients With Metastatic Colorectal Cancer and WT KRAS Tumours (MACRO-2)

Metastatic Colorectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...
Amgen

Completed

Safety and Efficacy Study of Panitumumab+Irinotecan in Patients Wild-Type (WT) KRAS Metastatic Colorectal Cancer Refractory to Irinotecan Based Chemotherapy (SPECTRA) (SPECTRA)

Metastatic Colorectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...
Merck Sharp & Dohme LLC

Terminated

Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.

Metastatic Colorectal Cancer

Spain
Associacio catalana per a la recerca oncologica...
Amgen

Unknown

A Clinical Trial of Panitumumab in Combination With FOLFIRI Chemotherapy as Second Line Treatment in Subjects With Metastatic Colorectal Cancer Expressing Wild-type KRAS and Who Had Progressed ≥ 6 Months After the Last Dose of the First Line Chemotherapy (ACTIVE)

Metastatic Colorectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...
Roche Pharma AG

Completed

Influence of BRAF and PIK3K Status on the Efficacy of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFIRI) Plus Bevacizumab or Cetuximab in Patients With RAS Wild-type Metastatic Colorectal Carcinoma and < 3 Circulating Tumor Cells (CTC) (VISNU-2)

Colorectal Cancer Metastatic

Spain
Instituto de Investigación Sanitaria Aragón
Hospital Clínico Universitario Lozano Blesa; FEIRACO LACTEOS SL

Recruiting

Effects of UNICLA-A2 Dairy Products on Patients at High-risk of Colorectal Cancer Development

Colorectal Polyp

Spain
Bayer

Completed

RE-SEARCH Study: A Study to Learn How and in Which Amount Regorafenib is Given in Usual Practice to Patients in Spain: a Study Looking Back at Cases That Have Already Happened When the Study Begins. (RE-SEARCH)

Metastatic Colorectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...
Roche Pharma AG

Completed

Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells (VISNU-1)

Metastatic Colorectal Cancer

Spain
Hospital General Universitario Reina Sofía de Murcia

Unknown

Postoperative Diet With Hyperproteic Supplement Versus a Supplement With Imunonutrients, in Colorectal Cancer Surgery (NUTRICOLON)

Colorectal Cancer | Surgery--Complications | Site Infection | Nutrition Support | Nutrition Related Neoplasm/Cancer

Spain
Spanish Cooperative Group for the Treatment of...

Completed

Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques (ULTRA)

Stage IV Colorectal Cancer

Spain
City of Hope Medical Center

Recruiting

Predicting Local and Distant Recurrence in T1 Colorectal Cancer (T1CR)

Colorectal Neoplasms | Colorectal Cancer | Colorectal Adenocarcinoma | Colorectal Neoplasms Malignant | Colorectal Cancer Stage I | Colorectal Cancer Recurrent

United States, Japan, Spain
Bayer

Active, not recruiting

A Real-World Study to Learn More About the Order of Different Treatments and Their Effects in People With Metastatic Colorectal Cancer Receiving Their Third and Fourth Line of Treatment (RegoSeq)

Metastatic Colorectal Cancer

Spain, Italy, France
Fundacion para la Formacion e Investigacion Sanitarias...

Recruiting

Gut Microbiome Modification Through Dietary Intervention in Patients With Colorectal Cancer: Response to Surgery

Colorectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...
Amgen

Active, not recruiting

Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal Cancer (CR-SEQUENCE)

Colorectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...

Completed

Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer

Colorectal Cancer

Spain
Universidad de Granada

Withdrawn

A Mobile Aplication for the Promotion of Healthy Lifestyle Habits in Patients With Colorectal Cancer

Colorectal Cancer

Spain
Instituto de Investigación Sanitaria Aragón
G. d'Annunzio University; Instituto de Salud Carlos III; Hospital Clínico Universitario...

Unknown

Assessment of Direct Biomarkers of Aspirin Action to Develop a Precision Chemoprevention Therapy of Colorectal Cancer

Colorectal Cancer

Spain
Universidad Complutense de Madrid
Hospital General Universitario Gregorio Marañon

Completed

Inflammatory Response After Colorectal Cancer Surgery (CRC)

Colorectal Cancer

Spain
Universidad de Granada

Completed

Core Stability Program in Colorectal Cancer Survivors

Colorectal Cancer

Spain
National Research Council, Spain
Hospital Universitario Reina Sofia de Cordoba

Completed

Pomegranate Extract Supplementation in Colorectal Cancer Patients (POMEcolon)

Colorectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...
Sanofi; Roche Pharma AG

Completed

Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients

Colorectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer

Colorectal Cancer

Spain
Fundació Institut de Recerca de l'Hospital de la...

Unknown

Micrometastases and Angiogenesis in Colon Cancer. Prognostic Value of VEGF. (VEGF-GC)

Colorectal Cancer | Angiogenesis

Spain
Fundacion Clinic per a la Recerca Biomédica

Recruiting

Validation of a microRNA-based Fecal (miRFec) Test for Colorectal Cancer Screening (miRFec)

Colorectal Cancer

Spain
Parc de Salut Mar

Completed

Low-fiber Diet for Colorectal Cancer Screening Colonoscopy (DIETCOL)

Colonic Diseases

Spain
Spanish Cooperative Group for the Treatment of...
Hoffmann-La Roche

Completed

Selecting Treatment in Colorectal Cancer:Capecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal Cancer (SETICC)

Colorectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...
Amgen

Completed

Study of First-line Single-agent Panitumumab in Frail Elderly Patients With Advanced Wild Type K-RAS Colorectal Cancer (FRAIL)

Colorectal Cancer

Spain
Grupo Hospital de Madrid

Unknown

Angiogenic Switch in Patients With Colorectal Cancer (ANGIOSWITCH)

Colorectal Cancer

Spain
Aragon Institute of Health Sciences
G. d'Annunzio University; Catholic University, Italy

Unknown

Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of Action

Colorectal Cancer

Spain
Enrique Quintero

Completed

Colorectal Cancer Screening in Familiar-Risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy (COLONFAM)

Colorectal Cancer

Spain
Hospital Universitario La Fe

Completed

MOR-1 Expression in Colorectal Cancer and Disease-free Survival Relationship. Five-year Follow-up. (MOROCCO)

Colorectal Cancer

Spain
Hospital Universitari de Bellvitge

Unknown

Study to Evaluate Oxygen Monitoring at Different Stages of Neuromuscular Blockade in Colorectal Surgery (OXYMUBLOC)

Colorectal Cancer

Spain
Hospital Provincial de Castellon

Completed

Effectiveness and Safety of the Colonoscopy Assisted by Endocuff vs. Standard in the Colorectal Cancer Screening

Cancer Colorectal

Spain
Fundació Institut de Recerca de l'Hospital de la...

Unknown

Study to Evaluate the Efficacy and Safety of FOLFIRI-AD in Patients With Metastatic Colorectal Cancer UGT1A Genotype 1 (FOLFIRI-AD)

Metastatic Colorectal Cancer

Spain
Grupo Espanol Multidisciplinario del Cancer Digestivo

Recruiting

Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease (LIVERPEARL)

Colorectal Cancer Metastatic | Liver Metastasis Colon Cancer

Spain
EMD Serono

Terminated

MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)

Metastatic Colorectal Cancer

Italy, Spain, Belgium

3

Subscribe